Brigit Biofarmaka Teknologi Tbk. vs Semen Baturaja Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Semen Baturaja Tbk. trades at Rp164 (market cap 1.56T, 7.56M 24h volume). The key difference: Semen Baturaja Tbk. is far larger — about 9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Semen Baturaja Tbk. is more actively traded (7.56M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | SMBR | |
|---|---|---|
Market Cap | 172.82B | 1.56T |
Volume | 592.2K | 7.56M |
Lot | 5.92K | 75.59K |
Turnover | 147.05M | 1.23B |
Average Price | 248.31 | 163.33 |
Value | 147.05M | 1.23B |
Indicative Equilibrium Price | 254 | 164 |
Indicative Equilibrium Volume | 10 | 254 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Semen Baturaja (Persero) Tbk (the Company) was established by Deed of Notary Jony Frederik Berthold Tumbelaka Sinjai No. 34, in Jakarta, dated November 14, 1974, amended by the same notary on November 21, 1974, amended by the same notary on November 21, 1974 Deed No. 49.
Read more on SMBR →